These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3031577)

  • 21. Zoster immune plasma prophylaxis of varicella: a follow-up report.
    Balfour HH; Groth KE
    J Pediatr; 1979 May; 94(5):743-6. PubMed ID: 221631
    [No Abstract]   [Full Text] [Related]  

  • 22. Varicella-zoster virus infection in a pediatric oncology unit.
    Kirk JA; Menser MA; Bergin M; Stevens MM; De Silva LM
    Pediatr Infect Dis J; 1988 Jul; 7(7):520-2. PubMed ID: 2841640
    [No Abstract]   [Full Text] [Related]  

  • 23. Volume of varicella-zoster immune globulin.
    Marchant CD; Leszczynski J
    Pediatr Infect Dis J; 1991 Jun; 10(6):476. PubMed ID: 1649433
    [No Abstract]   [Full Text] [Related]  

  • 24. Varicella-zoster virus infection. The complex prevention-treatment picture.
    Brody MB; Moyer D
    Postgrad Med; 1997 Jul; 102(1):187-90, 192-4. PubMed ID: 9224486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.
    Wurzel CL; Rubin LG; Krilov LR
    Pediatr Infect Dis J; 1987 May; 6(5):466-70. PubMed ID: 3037474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
    Geiser CF; Bishop Y; Myers M; Jaffe N; Yankee R
    Cancer; 1975 Apr; 35(4):1027-30. PubMed ID: 46775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoster immune globulin. A further assessment.
    Gershon AA; Steinberg S; Brunell PA
    N Engl J Med; 1974 Jan; 290(5):243-5. PubMed ID: 4358055
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with varicella zoster immunoglobulin in Hungary].
    Nyerges G; Mészner Z; Héjjas M
    Orv Hetil; 1982 May; 123(22):1347-50. PubMed ID: 6287381
    [No Abstract]   [Full Text] [Related]  

  • 29. [Letter: Varicella prevention in persons with impaired immunoapparatus].
    Seip M; Lie SO
    Tidsskr Nor Laegeforen; 1974 Oct; 94(28):1934-5. PubMed ID: 4371630
    [No Abstract]   [Full Text] [Related]  

  • 30. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
    Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
    Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Varicella-zoster-immunoglobulin as a safe prophylaxis of varicella (author's transl)].
    Kornhuber B; Kropp H; Ribeiro-Ayeh J; Hinderfeld L; Welte K
    Monatsschr Kinderheilkd; 1982 Jan; 130(1):27-9. PubMed ID: 6278297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir in prophylaxis and perinatal varicella.
    Lancet; 1987 Jan; 1(8525):161. PubMed ID: 2879995
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: Varicella-zoster infections: zoster immune globulin.
    Hussey HH
    JAMA; 1974 May; 228(7):876. PubMed ID: 4362716
    [No Abstract]   [Full Text] [Related]  

  • 35. [Letter: Prevention against varicella and herpes zoster in individuals with impaired immunological defence].
    Moe FJ
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2409. PubMed ID: 4374773
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of varicella in immunocompromised patients on unpredictable occurrence of the disease in a children's ward: vaccine-boostered immune whole blood transfusion (VIB) method.
    Hirao T
    Biken J; 1984 Sep; 27(2-3):137-41. PubMed ID: 6100052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of zoster immune globulin.
    Judelsohn RG; Meyers JD; Ellis RJ; Thomas EK
    Pediatrics; 1974 Apr; 53(4):476-80. PubMed ID: 4823323
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chickenpox prevention in patients at risk with a special immunoglobulin].
    Thomas E; Enders-Ruckle G; Geursen RG
    Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of varicella-zoster virus infections. No systematic vaccination against varicella in France].
    Lorette G
    Presse Med; 1998 Jul 4-11; 27(24):1237. PubMed ID: 9767786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.